| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/12/1996 | WO1996039489A1 Isolation of mammalian hematopoietic stem cells |
| 12/12/1996 | WO1996039428A1 Antitumor proteins from rana pipiens oocytes |
| 12/12/1996 | WO1996039372A2 Macrophage lipid chemoattractant |
| 12/12/1996 | WO1996039208A1 Device and method for concentrating plasma |
| 12/12/1996 | WO1996039196A1 Gene transfer for treating a connective tissue of a mammalian host |
| 12/12/1996 | WO1996039174A1 Method for rapid enzymatic alcohol removal |
| 12/12/1996 | WO1996039171A1 Therapy using lymphotoxin and thrombopoietin |
| 12/12/1996 | WO1996039128A1 Protein particles for therapeutic and diagnostic use |
| 12/12/1996 | WO1996039098A1 A device for delivering a preselected molecule into the system circulation |
| 12/12/1996 | WO1996039035A1 Myogenic differentiation of human mesenchymal stem cells |
| 12/12/1996 | WO1996039026A1 Method using oxygen removal for extending the useful shelf-life of refrigerated red blood cells |
| 12/12/1996 | WO1996033282A3 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
| 12/12/1996 | CA2224176A1 Gene transfer for treating a connective tissue of a mammalian host |
| 12/12/1996 | CA2223492A1 Isolation of mammalian hematopoietic stem cells |
| 12/12/1996 | CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 12/12/1996 | CA2222880A1 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 12/12/1996 | CA2222060A1 Method for rapid enzymatic alcohol removal |
| 12/12/1996 | CA2222040A1 Macrophage lipid chemoattractant |
| 12/12/1996 | CA2221711A1 Chimeric proteins for use in transport of a selected substance into cells |
| 12/12/1996 | CA2221258A1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 12/12/1996 | CA2220895A1 Protein particles for therapeutic and diagnostic use |
| 12/12/1996 | CA2220336A1 Therapy using lymphotoxin and thrombopoietin |
| 12/12/1996 | CA2218329A1 Fibroblast growth factor-11 |
| 12/11/1996 | EP0747383A2 Polyamine salts of clavulanic acid |
| 12/11/1996 | EP0747044A1 Process for production of seawater used for disintegrating cerumen |
| 12/11/1996 | EP0747041A2 Petroleum jelly containing cosmetic composition |
| 12/11/1996 | EP0746625A1 Targetable vector particles |
| 12/11/1996 | EP0746624A1 Vector for liver-specific gene therapy |
| 12/11/1996 | EP0746343A1 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE $i(IN VIVO) OR $i(EX VIVO) |
| 12/11/1996 | EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 12/11/1996 | EP0746329A1 Anti-inflammatory factor, method of isolation, and use |
| 12/11/1996 | EP0746325A1 Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation |
| 12/11/1996 | EP0644887B1 Intermediates in a process for the purification of clavulanic acid |
| 12/11/1996 | CN1137758A Methods of prolonged suppression of humoral immunity |
| 12/11/1996 | CN1137515A Method for preparation of nutural pearl clam internal organs full composition hydrolysate and docosahexenoic acid and eicosapentaenoic acid |
| 12/11/1996 | CN1137413A Yuxianwan pill for curing psoriasis |
| 12/11/1996 | CN1137407A Quick-acting Duangusan powder capable of setting of fracture in 2-6 hours |
| 12/11/1996 | CN1137404A Drug for curing pulmonary tuberculosis |
| 12/11/1996 | CN1137401A Method for preparation of tortoise extract |
| 12/11/1996 | CN1137393A Yisuishengxue Chinese medicine preparation for tonifying marrow and promoting generation of blood |
| 12/11/1996 | CN1137385A Quick-acting Chinese medicine "Jiangtang Fumingwan" pill for curing diabetes and complication and its preparation technology |
| 12/11/1996 | CN1137383A Yigan Kangyangsan powder for curing hepatitis B |
| 12/11/1996 | CN1137382A Traditional Chinese medicine health care oral liquor and its preparation method |
| 12/10/1996 | USRE35399 Composite living skin equivalents |
| 12/10/1996 | US5583224 Isolation and elucidation of cephalostatin 7, 8 and 9 |
| 12/10/1996 | US5583111 Water soluble leech extract |
| 12/10/1996 | US5583033 T lymphocyte precursor |
| 12/07/1996 | CA2178256A1 Oncostatin m induced hematopoiesis |
| 12/05/1996 | WO1996038576A1 Human oligodendroglial progenitor cell line |
| 12/05/1996 | WO1996038544A1 Porcine cardiomyocytes and their use in treatment of insufficient cardiac function |
| 12/05/1996 | WO1996038543A1 Modified cells and methods for inhibiting xenograft rejection |
| 12/05/1996 | WO1996038482A1 Monoclonal antibodies for human mesenchymal stem cells |
| 12/05/1996 | WO1996038188A1 Inhibition of vascular occlusion following vascular intervention |
| 12/05/1996 | WO1996038178A1 Allogeneic and xenogeneic transplantation |
| 12/05/1996 | WO1996038159A1 Micro-encapsulated lactobacilli for medical applications |
| 12/05/1996 | CA2219851A1 Porcine cardiomyocytes and their use in treatment of insufficient cardiac function |
| 12/05/1996 | CA2217131A1 Modified cells and methods for inhibiting xenograft rejection |
| 12/04/1996 | EP0745132A1 Method for preparing orphan receptor ligands |
| 12/04/1996 | EP0745131A1 Targeting gene therapy |
| 12/04/1996 | EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development |
| 12/04/1996 | EP0745125A1 Hematopoietic protein and materials and methods for making it |
| 12/04/1996 | EP0744892A1 Controlling donor blood characteristics |
| 12/04/1996 | CN1137292A Purification of vitamin-K dependent proteins by membrane chromatography |
| 12/04/1996 | CN1136960A Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels |
| 12/04/1996 | CN1136959A "Shuangzhuyuye" liquid-health beverage |
| 12/04/1996 | CN1136956A Compound pill of trachitis |
| 12/04/1996 | CN1136953A Medicine for treating diabetes |
| 12/04/1996 | CN1136952A Medicine for treating mastadenitis |
| 12/04/1996 | CN1136939A Chinese drugs for curing hepatitis B |
| 12/04/1996 | CN1136932A Oral liquid for strengthening bone |
| 12/04/1996 | CN1136931A Ant ginseng oral liquid and preparing process thereof |
| 12/04/1996 | CN1136926A Chinese medicine for treating acute and chronic nephritis |
| 12/04/1996 | CN1136924A Natural ant capsule and producing process thereof |
| 12/04/1996 | CN1136923A "Zhenmi" eye drops |
| 12/03/1996 | US5580781 Three-dimensional tumor cell and tissue culture system |
| 12/03/1996 | US5580757 Culturing mammalian cell transformed with recombinant vector including nucleotide sequence encoding cleavage site sandwiched between galactosidase and protein a coding sequences, recovering expressed fusion protein, cleaving |
| 12/03/1996 | US5580714 Concentrated solution consists of glycerol, an alkali metal chloride, a monosaccharide and human serum albumin |
| 12/03/1996 | US5580561 Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide |
| 12/03/1996 | US5580558 Delivery of gene products via mesangial cells |
| 12/03/1996 | US5580297 Royal jelly |
| 11/28/1996 | WO1996037623A1 Retroviral vectors |
| 11/28/1996 | WO1996037616A1 Alphavirus rna replicon systems |
| 11/28/1996 | WO1996037602A1 Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function |
| 11/28/1996 | WO1996037601A1 Cell differentiation agents |
| 11/28/1996 | WO1996037230A1 Immunostimulating-wound healing compositions and methods for preparing and using same |
| 11/28/1996 | WO1996037229A1 Antihistamine-wound healing compositions and methods for preparing and using same |
| 11/28/1996 | WO1996037228A1 Antibacterial-wound healing compositions and methods for preparing and using same |
| 11/28/1996 | WO1996037227A1 Dermatological-wound healing compositions and methods for preparing and using same |
| 11/28/1996 | WO1996037208A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
| 11/28/1996 | CA2220971A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
| 11/28/1996 | CA2220007A1 Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function |
| 11/28/1996 | CA2218817A1 Cell differentiation agents |
| 11/28/1996 | CA2218539A1 Immunostimulating-wound healing compositions and methods for preparing and using same |
| 11/27/1996 | EP0743957A1 Plasma concentrate and tissue sealant compositions |
| 11/27/1996 | EP0743856A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 11/27/1996 | EP0743820A1 Myoblast therapy for mammalian diseases |
| 11/27/1996 | CN1136826A Recombinant P53 adenovirus method and compositions |
| 11/27/1996 | CN1136778A Sperm antigen corresponding to sperm zone binding protein autoantigenic epitope |
| 11/27/1996 | CN1136777A Immunomodulating compositions from bile |
| 11/27/1996 | CN1136589A 花粉啤酒 Pollen beer |